Citation: | WU Xiaoxue, CHEN Hongzhen, ZHENG Kun, YU Hongmei, XIA Li. Correlation between hypertension and sarcopenia in the community-dwelling older residents[J]. Chinese Journal of General Practice, 2024, 22(8): 1371-1375. doi: 10.16766/j.cnki.issn.1674-4152.003639 |
[1] |
CRUZ-JENTOFT A J, BAHAT G, BAUER J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age and Ageing, 2019, 48(1): 16-31. doi: 10.1093/ageing/afy169
|
[2] |
TSAO C W, ADAY A W, ALMARZOOQ Z I, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association[J]. Circulation, 2023, 147(8): e93-e621.
|
[3] |
QUAN Y, WANG C, WANG L, et al. Geriatric sarcopenia is associated with hypertension: a systematic review and meta-analysis[J]. J Clin Hypertens(Greenwich), 2023, 25(9): 808-816. doi: 10.1111/jch.14714
|
[4] |
EKIZ T, KARA M, ATA A M, et al. Rewinding sarcopenia: a narrative review on the renin-angiotensin system[J]. Aging Clin Exp Res, 2021, 33(9): 2379-2392. doi: 10.1007/s40520-020-01761-3
|
[5] |
廖书雯, 刘利利, 赵柯湘, 等. 重庆市养老院人群肌肉减少症患病率调查及相关危险因素分析[J]. 国际老年医学杂志, 2018, 39(1): 1-5, 21. doi: 10.3969/j.issn.1674-7593.2018.01.001
LIAO S W, LIU L L, ZHAO K X, et al. Prevalence and risk factors of sarcopenia in Chongqing ' s nursing home[J]. International Journal of Geriatrics, 2018, 39(1): 1-5, 21. doi: 10.3969/j.issn.1674-7593.2018.01.001
|
[6] |
ATA A M, KARA M, EKIZ T, et al. Reassessing sarcopenia in hypertension: STAR and ACE inhibitors excel[J]. Int J Clin Pract, 2021, 75(3): e13800. DOI: 10.1111/ijcp.13800.
|
[7] |
ENDO T, AKAI K, KIJIMA T, et al. An association analysis between hypertension, dementia, and depression and the phases of pre-sarcopenia to sarcopenia: a cross-sectional analysis[J]. PLoS One, 2021, 16(7): e0252784. DOI: 10.1371/journal.pone.0252784.
|
[8] |
CHEN L-K, WOO J, ASSANTACHAI P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020, 21(3): 300-307. e2. doi: 10.1016/j.jamda.2019.12.012
|
[9] |
GAO Q, HU K, YAN C, et al. Associated factors of sarcopenia in community-dwelling older adults: a systematic review and meta-analysis[J]. Nutrients, 2021, 13(12): 4291. DOI: 10.3390/nu13124291.
|
[10] |
中国肥胖问题工作组数据汇总分析协作组. 我国成人体重指数和腰围对相关疾病危险因素异常的预测价值: 适宜体重指数和腰围切点的研究[J]. 中华流行病学杂志, 2002, 23(1): 5-10. doi: 10.3760/j.issn:0254-6450.2002.01.003
China Obesity Working Group Data summary and analysis cooperation group. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population[J]. Chinese Journal of Epidemiology, 2002, 23(1): 5-10. doi: 10.3760/j.issn:0254-6450.2002.01.003
|
[11] |
中国高血压防治指南修订委员会, 高血压联盟(中国), 中华医学会心血管病学分会中国医师协会高血压专业委员会, 等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1): 24-56. doi: 10.3969/j.issn.1007-5410.2019.01.002
Chinese Hypertension Prevention Guidelines Revision Committee, Hypertension Alliance (China), Chinese Medical Doctor Association Hypertension Professional Committee, Chinese Association of Cardiology Branch, et al. 2018 Chinese guidelines for the management of hypertension[J]. Chinese Journal of Cardiovascular Medicine, 2019, 24(1): 24-56. doi: 10.3969/j.issn.1007-5410.2019.01.002
|
[12] |
KINGSLEY J, TORIMOTO K, HASHIMOTO T, et al. Angiotensin Ⅱ inhibition: a potential treatment to slow the progression of sarcopenia[J]. Clin Sci(Lond), 2021, 135(21): 2503-2520. doi: 10.1042/CS20210719
|
[13] |
KUO Y H, WANG T F, LIU L K, et al. Epidemiology of sarcopenia and factors associated with it among community-dwelling older adults in Taiwan[J]. Am J Med Sci, 2019, 357(2): 124-133. doi: 10.1016/j.amjms.2018.11.008
|
[14] |
BUVINIC S, BALANTA-MELO J, KUPCZIK K, et al. Muscle-bone crosstalk in the masticatory system: from biomechanical to molecular interactions[J]. Front Endocrinol(Lausanne), 2021, 11: 606947. DOI: 10.3389/fendo.2020.606947.
|
[15] |
马璐瑶, 林萍, 王琴, 等. 老年慢性心力衰竭患者肌少症的筛查及干预研究[J]. 中华全科医学, 2022, 20(3): 419-423. doi: 10.16766/j.cnki.issn.1674-4152.002367
MA L Y, LIN P, WANG Q, et al. Screening and intervention of sarcopoenia in elderly patients with chronic heart failure[J]. Chinese Journal of General Practice, 2022, 20(3): 419-423. doi: 10.16766/j.cnki.issn.1674-4152.002367
|
[16] |
XING E, WAN C. Prevalence of and factors associated with sarcopenia among elderly individuals with hypertension[J]. J Int Med Res, 2022, 50(7): 03000605221110490. DOI: 10.1177/03000605221110490.
|
[17] |
赵旭冉, 高金娥, 娜日松, 等. 肌少症性肥胖与老年高血压的相关性临床研究[J]. 中华全科医学, 2022, 20(11): 1874-1877. doi: 10.16766/j.cnki.issn.1674-4152.002724
ZHAO X R, GAO J E, NA R S, et al. Clinical study on the correlation between sarcopenic obesity and hypertension in elderly subjects[J]. Chinese Journal of General Practice, 2022, 20(11): 1874-1877. doi: 10.16766/j.cnki.issn.1674-4152.002724
|
[18] |
BAI T, FANG F, LI F, et al. Sarcopenia is associated with hypertension in older adults: a systematic review and meta-analysis[J]. Bmc Geriatr, 2020, 20(1): 279. DOI: 10.1186/s12877-020-01672-y.
|
[19] |
MANCUSI C, IZZO R, DI GIOIA G, et al. Insulin resistance the hinge between hypertension and type 2 diabetes[J]. High Blood Press Cardiovasc Prev, 2020, 27(6): 515-526. doi: 10.1007/s40292-020-00408-8
|
[20] |
HE N, ZHANG Y, ZHANG L, et al. Relationship between sarcopenia and cardiovascular diseases in the elderly: an overview[J]. Front Cardiovasc Med, 2021, 8: 743710. DOI: 10.3389/fcvm.2021.743710.
|
[21] |
YAMAGUCHI R, KATAYAMA O, LEE S, et al. Association of sarcopenia and systolic blood pressure with mortality: a 5-year longitudinal study[J]. Arch Gerontol Geriatr, 2023, 110: 104988. DOI: 10.1016/j.archger.2023.104988.
|
[22] |
BU S Y. Association of skeletal muscle mass and risk of hypertension in Korean adults: secondary analysis of data from the community-based prospective cohort study[J]. Front Nutr, 2023, 10: 1254109. DOI: 10.3389/fnut.2023.1254109.
|